<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">

<html>
<head>
	
	<meta http-equiv="content-type" content="text/html; charset=utf-8"/>
	<title></title>
	<meta name="generator" content="LibreOffice 6.0.7.3 (Linux)"/>
	<meta name="author" content="Puis_5"/>
	<meta name="created" content="2021-02-13T00:27:18"/>
	<meta name="changedby" content="Gabriel García-Peña"/>
	<meta name="changed" content="2021-05-06T06:33:34.062479783"/>
	<meta name="AppVersion" content="16.0300"/>
	<meta name="DocSecurity" content="0"/>
	<meta name="HyperlinksChanged" content="false"/>
	<meta name="LinksUpToDate" content="false"/>
	<meta name="ScaleCrop" content="false"/>
	<meta name="ShareDoc" content="false"/>
	
	<style type="text/css">
		body,div,table,thead,tbody,tfoot,tr,th,td,p { font-family:"Arial"; font-size:15px; }
		a.comment-indicator:hover + comment { background:#ffd; position:absolute; display:block; border:1px solid black; padding:0.5em;  } 
		a.comment-indicator { background:red; display:inline-block; border:1px solid black; width:0.5em; height:0.5em;  } 
		comment { display:none;  } 
	</style>
	
</head>

<body>
<table align="center" cellspacing="1" border="3" style="background-color:rgba(5,61,182,0.1); width:90%;">
	<colgroup style="width:60%;"></colgroup>
	<colgroup style="min-width:20%;"></colgroup>
	<colgroup style="width:20%;"></colgroup>
	<colgroup style="width:10%;"></colgroup>
	<tr>
		<td height="19" align="left" valign=top><b>Titulo </b></td>
		<td align="left" valign=top><b>Tema </b></td>
		<td align="left" valign=top><b>Publicado en:</b></td>
		<td align="left" valign=top><b>Recurso </b></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Inmunización y COVID-19</font></td>
		<td align="left" valign=top><font color="#000000">General</font></td>
		<td align="left" valign=top><font color="#000000">WHO</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://who.canto.global/s/GMO6B?viewIndex=0&amp;from=curatedView&amp;display=curatedView">https://who.canto.global/s/GMO6B?viewIndex=0&amp;from=curatedView&amp;display=curatedView</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Información para entender cómo actúan las vacunas contra el COVID-19</font></td>
		<td align="left" valign=top><font color="#000000">General</font></td>
		<td align="left" valign=top><font color="#000000">CDC</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fvaccines%2Fabout-vaccines%2Fhow-they-work.html">https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fvaccines%2Fabout-vaccines%2Fhow-they-work.html</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">COVID-19 vaccines: where we stand and challenges ahead</font></td>
		<td align="left" valign=top><font color="#000000">General</font></td>
		<td align="left" valign=top><font color="#000000">Nature</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://doi.org/10.1038/s41418-020-00720-9">https://doi.org/10.1038/s41418-020-00720-9</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Evolution of the COVID-19 vaccine development landscape</font></td>
		<td align="left" valign=top><font color="#000000">General</font></td>
		<td align="left" valign=top><font color="#000000">Nature</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nature.com/articles/d41573-020-00151-8">https://www.nature.com/articles/d41573-020-00151-8</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process (20 January 2021)</font></td>
		<td align="left" valign=top><font color="#000000">General</font></td>
		<td align="left" valign=top><font color="#000000">WHO</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_20Jan2021_v2.pdf">https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_20Jan2021_v2.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">27th WHO Regulatory Update on COVID-19</font></td>
		<td align="left" valign=top><font color="#000000">General</font></td>
		<td align="left" valign=top><font color="#000000">WHO</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.who.int/docs/default-source/medicines/regulatory-updates/covid-19/27th-who-regulatory-update-on-covid-19_24jan2021.pdf?sfvrsn=44a850d6_5&amp;download=true">https://www.who.int/docs/default-source/medicines/regulatory-updates/covid-19/27th-who-regulatory-update-on-covid-19_24jan2021.pdf?sfvrsn=44a850d6_5&amp;download=true</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Product Information as approved by the CHMP on 29 January 2021, pending endorsement by the European Commission</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine AstraZeneca</font></td>
		<td align="left" valign=top><font color="#000000">EMA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-astrazeneca-product-information-approved-chmp-29-january-2021-pending-endorsement_en.pdf">https://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-astrazeneca-product-information-approved-chmp-29-january-2021-pending-endorsement_en.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Safety and efficacy of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine AstraZeneca</font></td>
		<td align="left" valign=top><font color="#000000"><br></font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Vacunas de Vectores virales | ChAdOx1 / AZD1222</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine AstraZeneca</font></td>
		<td align="left" valign=top><font color="#000000">AEP</font></td>
		<td align="left" valign=top><font color="#000000">https://vacunasaep.org/profesionales/noticias/covid-vacunas-vector-viral-ChAdOx1-Oxford-AstraZeneca</font></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Vacunas de vectores virales | ChAdOx1 nCoV-19</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine AstraZeneca</font></td>
		<td align="left" valign=top><font color="#000000">AEP</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://vacunasaep.org/profesionales/noticias/covid-vacunas-vector-viral-ChAdOx1-Oxford-AstraZeneca">https://vacunasaep.org/profesionales/noticias/covid-vacunas-vector-viral-ChAdOx1-Oxford-AstraZeneca</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Cansino</font></td>
		<td align="left" valign=top><font color="#000000">Nature</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nature.com/articles/s41467-020-17972-1">https://www.nature.com/articles/s41467-020-17972-1</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Safety and efficacy of an rAd26 and rAd5 vector-based heterologus prime-boost COVD19</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Gamaleya Reas. Inst.<br> (Sputnik V)</font></td>
		<td align="left" valign=top><font color="#000000">The lancet</font></td>
		<td align="left" valign=top><u><font color="#0563C1">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext#back-bib12</font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Safety ans efficacy of the BNT162b2 mRNA Covid-19 Vaccine</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Gamaleya Reas. Inst.<br> (Sputnik V)</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><u><font color="#0563C1">https://www.nejm.org/doi/full/10.1056/NEJMoa2034577</font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Sputnik V COVID-19 vaccine candidate appears safe and effective</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Gamaleya Reas. Inst.<br> (Sputnik V)</font></td>
		<td align="left" valign=top><font color="#000000">The lancet</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/fulltext">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/fulltext</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">The arrival of Sputnik V</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Gamaleya Reas. Inst.<br> (Sputnik V)</font></td>
		<td align="left" valign=top><font color="#000000">The lancet</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2034577">https://www.nejm.org/doi/full/10.1056/NEJMoa2034577</a></font></u></td>
	</tr>
	<tr>
		<td height="52" align="left" valign=top><font color="#000000">Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 spike immunogen induces potent humoral and cellular immune response</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Jhonson&amp;Jhonson</font></td>
		<td align="left" valign=top><font color="#000000">Nature</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nature.com/articles/s41541-020-00243-x">https://www.nature.com/articles/s41541-020-00243-x</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Interim results of a Phase 1-2a trial od Ad26.COV2.S Covid-19 Vaccine</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Jhonson&amp;Jhonson</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nejm.org/doi/10.1056/NEJMoa2034201">https://www.nejm.org/doi/10.1056/NEJMoa2034201</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Low-dose Ad26.COV2.S Protection against SARS-CoV-2 challenge in rhesus macaques</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Jhonson&amp;Jhonson</font></td>
		<td align="left" valign=top><font color="#000000">bioRxiv</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.biorxiv.org/content/10.1101/2021.01.27.428380v1">https://www.biorxiv.org/content/10.1101/2021.01.27.428380v1</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Single-shot Ad26 Vaccine Protects against SARS-CoV-2 in rhesus macaques</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine Jhonson&amp;Jhonson</font></td>
		<td align="left" valign=top><font color="#000000">Nature</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nature.com/articles/s41586-020-2607-z#:~:text=In%20summary%2C%20our%20data%20demonstrate,2%20challenge%20in%20rhesus%20macaques.">https://www.nature.com/articles/s41586-020-2607-z#:~:text=In%20summary%2C%20our%20data%20demonstrate,2%20challenge%20in%20rhesus%20macaques.</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">An evidence based perspective on mRNA-SARS-CoV-2 vaccine development</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">Med Sci Monit.&nbsp;</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://dx.doi.org/10.12659%2FMSM.924700">https://dx.doi.org/10.12659%2FMSM.924700</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Efficacy and safety of the mRNA-1273 SARS-Cov2 Vaccine</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><font color="#000000">10.1056/NEJMoa2035389</font></td>
	</tr>
	<tr>
		<td height="52" align="left" valign=top><font color="#000000">COVID-19 Vaccine Moderna (COVID-19 mRNA vaccine<br>[nucleoside modified]) An overview of COVID-19 Vaccine Moderna and why it is authorised in the EU</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">EMA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.ema.europa.eu/en/documents/overview/covid-19-vaccine-moderna-epar-medicine-overview_en.pdf">https://www.ema.europa.eu/en/documents/overview/covid-19-vaccine-moderna-epar-medicine-overview_en.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Moderna. Ficha Técnica</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">EMA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-moderna-epar-product-information_es.pdf">https://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-moderna-epar-product-information_es.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">COVID-19 mRNA vaccine Risk Management Plan (RMP)</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">EMA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.ema.europa.eu/en/documents/rmp-summary/covid-19-vaccine-moderna-epar-risk-management-plan_en.pdf">https://www.ema.europa.eu/en/documents/rmp-summary/covid-19-vaccine-moderna-epar-risk-management-plan_en.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Durability of responses after SARS-CoV-2 mRNA-1273 vaccination</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><font color="#000000">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</font></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2024671">https://www.nejm.org/doi/full/10.1056/NEJMoa2024671</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Moderna COVID-19 Vaccine<br>Vaccine Preparation and Administration Summary</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">CDC</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/downloads/prep-and-admin-summary.pdf">https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/downloads/prep-and-admin-summary.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Safety ans immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2028436">https://www.nejm.org/doi/full/10.1056/NEJMoa2028436</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Hoja informativa para receptores y cuidadores</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">FDA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.fda.gov/media/144712/download">https://www.fda.gov/media/144712/download</a></font></u></td>
	</tr>
	<tr>
		<td height="52" align="left" valign=top><font color="#000000">The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020</font></td>
		<td align="left" valign=top><font color="#000000">Moderna</font></td>
		<td align="left" valign=top><font color="#000000">CDC</font></td>
		<td align="left" valign=top><font color="#000000">https://www.cdc.gov/mmwr/volumes/69/wr/mm695152e2.htm</font></td>
	</tr>
	<tr>
		<td height="52" align="left" valign=top><font color="#000000">NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower<br>airways against SARS-CoV-2 challenge</font></td>
		<td align="left" valign=top><font color="#000000">Novavax</font></td>
		<td align="left" valign=top><font color="#000000">Vaccine</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://doi.org/10.1016/j.vaccine.2020.10.064">https://doi.org/10.1016/j.vaccine.2020.10.064</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine</font></td>
		<td align="left" valign=top><font color="#000000">Novavax</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2026920">https://www.nejm.org/doi/full/10.1056/NEJMoa2026920</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice</font></td>
		<td align="left" valign=top><font color="#000000">Novavax</font></td>
		<td align="left" valign=top><font color="#000000">Nature</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nature.com/articles/s41467-020-20653-8">https://www.nature.com/articles/s41467-020-20653-8</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Ficha técnica o resumen de las características del producto</font></td>
		<td align="left" valign=top><font color="#000000">Pfizer-BioNTech</font></td>
		<td align="left" valign=top><font color="#000000">EMA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty">https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Pfizer COVID-19 EUA Letter of Authorization reissued 122320</font></td>
		<td align="left" valign=top><font color="#000000">Pfizer-BioNTech</font></td>
		<td align="left" valign=top><font color="#000000">FDA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.fda.gov/media/144412/download">https://www.fda.gov/media/144412/download</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Pfizer COVID-19 Vaccine EUA Fact sheet for Recipients 1.25.2021</font></td>
		<td align="left" valign=top><font color="#000000">Pfizer-BioNTech</font></td>
		<td align="left" valign=top><font color="#000000">FDA</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.fda.gov/media/144414/download">https://www.fda.gov/media/144414/download</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Safety ans efficacy of the BNT162b2 mRNA Covid-19 Vaccine</font></td>
		<td align="left" valign=top><font color="#000000">Pfizer-BioNTech</font></td>
		<td align="left" valign=top><font color="#000000">NEJM</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2034577">https://www.nejm.org/doi/full/10.1056/NEJMoa2034577</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">The Advisory Committee on Immunization Practices’ Interim Recommendation</font></td>
		<td align="left" valign=top><font color="#000000">Pfizer-BioNTech</font></td>
		<td align="left" valign=top><font color="#000000">CDC</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm">https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm</a></font></u></td>
	</tr>
	<tr>
		<td height="19" align="left" valign=top><font color="#000000">Resumen Vacunas de ARN | BioNTech &amp; Pfizer | BNT162b2 |</font></td>
		<td align="left" valign=top><font color="#000000">Pfizer-BioNTech</font></td>
		<td align="left" valign=top><font color="#000000">AEP</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://vacunasaep.org/sites/vacunasaep.org/files/vacunas_covid_-_arnm_-_bnt162b1_resumen_1dic2020.pdf">https://vacunasaep.org/sites/vacunasaep.org/files/vacunas_covid_-_arnm_-_bnt162b1_resumen_1dic2020.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Vacunas de ARN | BNT162b2 BioNTech, Mainz, Alemania &amp; Pfizer, EE. UU.</font></td>
		<td align="left" valign=top><font color="#000000">Pfizer-BioNTech</font></td>
		<td align="left" valign=top><font color="#000000">AEP</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://vacunasaep.org/sites/vacunasaep.org/files/vacunas_covid_-_arnm_-_bnt162b2_tabla_01dic2020.pdf">https://vacunasaep.org/sites/vacunasaep.org/files/vacunas_covid_-_arnm_-_bnt162b2_tabla_01dic2020.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="36" align="left" valign=top><font color="#000000">Ficha vacuna-Sinovac Life Science</font></td>
		<td align="left" valign=top><font color="#000000">Sinovac</font></td>
		<td align="left" valign=top><font color="#000000">Ministerio de Chile </font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://www.minsal.cl/wp-content/uploads/2021/01/Ficha-vacuna-Sinovac-Life-Science.pdf">https://www.minsal.cl/wp-content/uploads/2021/01/Ficha-vacuna-Sinovac-Life-Science.pdf</a></font></u></td>
	</tr>
	<tr>
		<td height="102" align="left" valign=top><font color="#000000">Double-Blind, Randomized, Placebo- Controlled Phase III Clinical Trial to Evaluate the Efficacy and safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial</font></td>
		<td align="left" valign=top><font color="#000000">Sinovac</font></td>
		<td align="left" valign=top><font color="#000000">Trials</font></td>
		<td align="left" valign=top><u><font color="#0563C1"><a href="https://doi.org/10.1186/s13063-020-04775-4">https://doi.org/10.1186/s13063-020-04775-4</a></font></u></td>
	</tr>
</table>
<!-- ************************************************************************** -->
</body>

</html>
